產品詳情
簡單介紹：
Anti-C6orf136抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C6orf136抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-C6orf136
Cat. Number:
Anti-C6orf136抗體KL-15219R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated Anti-C6orf136抗體with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf136 gene product has been provisionally designated C6orf136 pending further characterization.
Also known as:
Chromosome 6 open reading Anti-C6orf136抗體frame 136; Uncharacterized protein C6orf136; CF136_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C6orf136.
●
Predicted Molecular Weight:Anti-C6orf136抗體 36kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-C6orf136抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl015Mu02 骨成型蛋白受體1A(BMPR1A)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)
kl019Mu02 白介素8受體α(IL8Rα)多克隆抗體 Polyclonal Antibody to Interleukin 8 Receptor Alpha (IL8Ra)
kl020Mu01 唾液酸結合Ig樣凝集素3(SIGLEC3)多克隆抗體 Polyclonal Antibody to Sialic Acid Binding Ig Like Lectin 3 (SIGLEC3)
kl020Mu02 唾液酸結合Ig樣凝集素3(SIGLEC3)多克隆抗體 Polyclonal Antibody to Sialic Acid Binding Ig Like Lectin 3 (SIGLEC3)
kl021Mu02 睫狀神經營養因子(CNTF)多克隆抗體 Polyclonal Antibody to Ciliary Neurotrophic Factor (CNTF)
kl022Mu02 血管內皮細胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl024Mu02 ***腺來源血管內皮生長因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl025Mu02 嗜酸粒細胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl026Mu02 趨化因子C-C-基元配體3樣蛋白1(CCL3L1)多克隆抗體 Polyclonal Antibody to Chemokine C-C-Motif Ligand 3 Like Protein 1 (CCL3L1)
kl029Mu02 E選擇素(SELE)多克隆抗體 Polyclonal Antibody to Selectin, Endothelium (SELE)
kl031Mu02 凋亡相關因子配體(FASL)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL)
kl032Mu02 酸性成纖維細胞生長因子(FGF1)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl033Ov01 干擾素α(IFNα)多克隆抗體 Polyclonal Antibody to Interferon Alpha (IFNa)
kl034Mu02 成纖維細胞生長因子4(FGF4)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 4 (FGF4)
kl035Mu02 成纖維細胞生長因子6(FGF6)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 6 (FGF6)
kl036Bo01 成纖維細胞生長因子9(FGF9)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 9 (FGF9)
kl036Mu02 成纖維細胞生長因子9(FGF9)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 9 (FGF9)
kl037Mu02 纖連蛋白(FN)多克隆抗體 Polyclonal Antibody to Fibronectin (FN)
kl038Mu02 FMS樣酪氨酸激酶3配體(Flt3L)多克隆抗體 Polyclonal Antibody to FMS Like Tyrosine Kinase 3 Ligand (Flt3L)
